Cutler Group LP Intercept Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$12.53 - $21.71 $11,277 - $19,539	-900 Reduced 36.0%	1,600 $0
Q4 2022 Feb 07, 2023	SELL	$11.61 - $16.11 $200,853 - $278,703	-17,300 Reduced 87.37%	2,500 $0
Q3 2022 Oct 25, 2022	BUY	$12.21 - $19.7 $168,498 - $271,860	13,800 Added 230.0%	19,800 $5,000
Q2 2022 Aug 04, 2022	SELL	$11.23 - $19.59 $112,300 - $195,900	-10,000 Reduced 62.5%	6,000 $5,000
Q1 2022 Apr 14, 2022	BUY	$13.37 - $17.79 $211,246 - $281,082	15,800 Added 7900.0%	16,000 $35,000

Q2 2021 Jul 19, 2021	SELL	$15.46 - $24.5 $15,460 - $24,500	-1,000 Reduced 83.33%	200 $1,000
Q2 2020 Jul 22, 2020	BUY	$46.7 - $92.04 $14,010 - $27,612	300 Added 33.33%	1,200 $0
Q1 2020 May 07, 2020	SELL	$48.35 - $118.68 $91,865 - $225,492	-1,900 Reduced 67.86%	900 $3,000
Q4 2019 Feb 06, 2020	SELL	$57.36 - $124.1 $321,216 - $694,960	-5,600 Reduced 66.67%	2,800 $95,000
Q3 2019 Oct 28, 2019	BUY	$58.69 - $80.46 $410,830 - $563,220	7,000 Added 500.0%	8,400 $43,000
Q2 2019 Aug 09, 2019	SELL	$77.77 - $120.68 $995,456 - $1.54 Million	-12,800 Reduced 90.14%	1,400 $18,000
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $202,026 - $265,496	2,200 Added 18.33%	14,200 $105,000
Q4 2018 Feb 05, 2019	BUY	$85.79 - $126.46 $308,844 - $455,256	3,600 Added 42.86%	12,000 $98,000
Q3 2018 Nov 07, 2018	BUY	$88.49 - $127.55 $460,148 - $663,260	5,200 Added 162.5%	8,400 $273,000
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $174,000 - $248,443	2,900 Added 966.67%	3,200 $50,000
Q1 2018 May 11, 2018	SELL	$52.72 - $67.25 $263,600 - $336,250	-5,000 Reduced 94.34%	300 $1,000
Q4 2017 Jan 17, 2018	SELL	$58.2 - $72.76 $2.85 Million - $3.56 Million	-48,900 Reduced 90.22%	5,300 $4,000
Q3 2017 Oct 17, 2017	BUY	$57.01 - $118.75 $3.09 Million - $6.44 Million	54,200	54,200 $90,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account